08 May 2021
: Case report 
Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report
Rare coexistence of disease or pathology
Julie Byler1E*, Rebecca Harrison2E, Lindsey L. Fell3BDOI: 10.12659/AJCR.931616
Am J Case Rep 2021; 22:e931616
Table 1. Patient’s creatine kinase and creatinine levels throughout her admission, in relation to days following initial SARS-CoV-2 infection.
| Days after COVID-19 diagnosis | Creatine kinase (U/L) | Creatinine (mg/dL) |
|---|---|---|
| 35 | 243 | 1.74 |
| 39 (day of discharge from initial hospitalization for COVID-19) | 1.59 | |
| 45 (day of re-admission for weakness) | 8.31 | |
| 46 | 1775 | 8.47 |
| 47 | 1874 | 8.87 |
| 48 | 2731 | 9.83 |
| 49 | 4541 | 10.31 |
| 50 | 7785 | 10.94 |
| 51 (dialysis initiated) | 9400 | 7.5 |
| 52 | 9326 | 5.51 |
| 53 | 11 026 | 4.23 |
| 54 | 12 699 | 5.24 |
| 55 | 15 085 | 4.32 |
| 56 | 13 230 | 4.5 |
| 57 | 8790 | 2.82 |
| 58 | 7242 | 4.78 |
| 59 | 4427 | 3.59 |
| 60 | 3135 | 4.61 |
| 61 | 1595 | 3.08 |